FR2275426B1 - - Google Patents

Info

Publication number
FR2275426B1
FR2275426B1 FR7517230A FR7517230A FR2275426B1 FR 2275426 B1 FR2275426 B1 FR 2275426B1 FR 7517230 A FR7517230 A FR 7517230A FR 7517230 A FR7517230 A FR 7517230A FR 2275426 B1 FR2275426 B1 FR 2275426B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7517230A
Other languages
French (fr)
Other versions
FR2275426A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Medicine and Chemistry Inc
Original Assignee
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Medicine and Chemistry Inc filed Critical Research Institute for Medicine and Chemistry Inc
Publication of FR2275426A1 publication Critical patent/FR2275426A1/fr
Application granted granted Critical
Publication of FR2275426B1 publication Critical patent/FR2275426B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B39/00Halogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7517230A 1974-06-04 1975-06-03 Procede de fluoration de composes organiques satures Granted FR2275426A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24734/74A GB1513135A (en) 1974-06-04 1974-06-04 Fluorination process and fluoro steroids

Publications (2)

Publication Number Publication Date
FR2275426A1 FR2275426A1 (fr) 1976-01-16
FR2275426B1 true FR2275426B1 (US08124317-20120228-C00060.png) 1979-07-13

Family

ID=10216416

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7517230A Granted FR2275426A1 (fr) 1974-06-04 1975-06-03 Procede de fluoration de composes organiques satures

Country Status (21)

Country Link
US (2) US4036864A (US08124317-20120228-C00060.png)
JP (1) JPS514102A (US08124317-20120228-C00060.png)
AU (1) AU498203B2 (US08124317-20120228-C00060.png)
BE (1) BE829809A (US08124317-20120228-C00060.png)
CA (1) CA1064475A (US08124317-20120228-C00060.png)
CH (1) CH616397A5 (US08124317-20120228-C00060.png)
DE (1) DE2524618A1 (US08124317-20120228-C00060.png)
DK (1) DK248075A (US08124317-20120228-C00060.png)
ES (1) ES438166A1 (US08124317-20120228-C00060.png)
FR (1) FR2275426A1 (US08124317-20120228-C00060.png)
GB (1) GB1513135A (US08124317-20120228-C00060.png)
IE (1) IE41545B1 (US08124317-20120228-C00060.png)
IL (1) IL47418A (US08124317-20120228-C00060.png)
IN (1) IN142193B (US08124317-20120228-C00060.png)
IT (1) IT1035927B (US08124317-20120228-C00060.png)
LU (1) LU72637A1 (US08124317-20120228-C00060.png)
NL (1) NL7506547A (US08124317-20120228-C00060.png)
NO (1) NO751939L (US08124317-20120228-C00060.png)
NZ (1) NZ177688A (US08124317-20120228-C00060.png)
SE (1) SE7506339L (US08124317-20120228-C00060.png)
ZA (1) ZA753588B (US08124317-20120228-C00060.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1513135A (en) * 1974-06-04 1978-06-07 Res Inst For Med & Chem Inc Fluorination process and fluoro steroids
US5234680A (en) * 1989-07-31 1993-08-10 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
PT870757E (pt) * 1997-04-10 2002-09-30 Pfizer Derivados de adamantano substituidos por fluoro
DE19738196A1 (de) * 1997-09-02 1999-03-04 Hoechst Ag Verfahren zur Herstellung von Fluor enthaltenden Verbindungen in hoher Reinheit
TW466266B (en) * 1997-12-18 2001-12-01 Central Glass Co Ltd Gas for removing deposit and removal method using same
GB9924705D0 (en) * 1999-10-20 1999-12-22 F2 Chemicals Ltd Preparation of selectively fluorinated organic compounds
US6455728B1 (en) * 1999-11-01 2002-09-24 Air Products And Chemicals, Inc. Direct fluorination process for preparing high purity 2-fluoro-1,3-dicarbonyl compounds using oxygen as a radical scavenger
US7488847B2 (en) 2002-12-11 2009-02-10 Asahi Glass Company, Limited Fluorinated adamantane and its derivatives
EP1574497B1 (en) * 2002-12-11 2014-07-16 Asahi Glass Company, Limited Fluorinated adamantane derivatives
WO2005123653A1 (ja) 2004-06-16 2005-12-29 Asahi Glass Company, Limited フルオロアダマンタン誘導体
WO2005123650A1 (ja) * 2004-06-16 2005-12-29 Asahi Glass Company, Limited 新規なフッ素化されたアダマンタン誘導体
US20080275112A1 (en) * 2004-07-23 2008-11-06 Schreiner Peter R Invention Concerning Aminoadamantane Compounds
EP2053055A1 (de) * 2007-10-24 2009-04-29 Bayer Schering Pharma Aktiengesellschaft 11.beta.-Fluoro-3-acetoxyestra-3,5-dien-17-on und Verfahren zu seiner Herstellung
CN112979409B (zh) * 2019-12-13 2022-09-30 浙江省化工研究院有限公司 一种气相催化氯化制备3,3,3-三氯-1,1,1-三氟丙烷的方法
CN116003372B (zh) * 2022-09-14 2024-08-06 多氟多新材料股份有限公司 一种氟代碳酸乙烯酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH577949A5 (US08124317-20120228-C00060.png) * 1967-09-11 1976-07-30 Res Inst Medicine Chem
GB1513135A (en) * 1974-06-04 1978-06-07 Res Inst For Med & Chem Inc Fluorination process and fluoro steroids

Also Published As

Publication number Publication date
JPS514102A (US08124317-20120228-C00060.png) 1976-01-14
BE829809A (fr) 1975-12-03
DE2524618A1 (de) 1976-01-02
NZ177688A (en) 1978-03-06
AU498203B2 (en) 1979-02-22
IN142193B (US08124317-20120228-C00060.png) 1977-06-11
NO751939L (US08124317-20120228-C00060.png) 1975-12-05
ES438166A1 (es) 1977-02-01
GB1513135A (en) 1978-06-07
LU72637A1 (US08124317-20120228-C00060.png) 1976-03-17
CH616397A5 (US08124317-20120228-C00060.png) 1980-03-31
NL7506547A (nl) 1975-12-08
US4036864A (en) 1977-07-19
IL47418A0 (en) 1975-08-31
CA1064475A (en) 1979-10-16
IE41545B1 (en) 1980-01-30
FR2275426A1 (fr) 1976-01-16
US4284558A (en) 1981-08-18
IL47418A (en) 1979-11-30
SE7506339L (sv) 1975-12-05
IE41545L (en) 1975-12-04
DK248075A (da) 1975-12-05
AU8179575A (en) 1976-12-09
ZA753588B (en) 1976-05-26
IT1035927B (it) 1979-10-20

Similar Documents

Publication Publication Date Title
FR2282902B1 (US08124317-20120228-C00060.png)
FR2260120A1 (US08124317-20120228-C00060.png)
FR2285798B1 (US08124317-20120228-C00060.png)
FR2275426B1 (US08124317-20120228-C00060.png)
FI753562A (US08124317-20120228-C00060.png)
FR2286655B1 (US08124317-20120228-C00060.png)
FR2282422B1 (US08124317-20120228-C00060.png)
FR2295418B1 (US08124317-20120228-C00060.png)
DK56375A (US08124317-20120228-C00060.png)
FR2270156B1 (US08124317-20120228-C00060.png)
FR2271506A1 (US08124317-20120228-C00060.png)
AU495920B2 (US08124317-20120228-C00060.png)
JPS50101133U (US08124317-20120228-C00060.png)
CS169916B1 (US08124317-20120228-C00060.png)
AU7099174A (US08124317-20120228-C00060.png)
IN137939B (US08124317-20120228-C00060.png)
CH1107074A4 (US08124317-20120228-C00060.png)
BG21632A1 (US08124317-20120228-C00060.png)
BG19873A1 (US08124317-20120228-C00060.png)
CH600028A5 (US08124317-20120228-C00060.png)
CH1357474A4 (US08124317-20120228-C00060.png)
DD119171A5 (US08124317-20120228-C00060.png)
BG26152A1 (US08124317-20120228-C00060.png)
BG23188A1 (US08124317-20120228-C00060.png)
BG22732A1 (US08124317-20120228-C00060.png)

Legal Events

Date Code Title Description
ST Notification of lapse